plasma therapy market size was valued at $0.35 billion in 2020 and is projected to reach $0.69 billion by 2030 registering a CAGR of 8.50% from 2021 to 2030.

PORTLAND, OREGON, UNITED STATES, September 2, 2022 /EINPresswire.com/ -- Growth of the plasma therapy market is driven by rise in prevalence of life-threatening diseases, which includes various neurological system disorders such as chronic inflammatory demyelinating polyneuropathy (CIPD), idiopathic thrombocytopenic purpura (ITP), and multifocal motor neuropathy (MMN) is anticipated to augment growth of the global plasma therapy market.

Plasma therapy is used for treatment of many disorders such as hair loss, tendon injuries, acute injuries, post-surgical repair, and osteoarthritis and currently for treatment of COVID–19. Furthermore, several manufacturers are initiating plasma processing to tackle the spread of coronavirus across the world. Therefore, the global plasma therapy market is expected to witness significant growth during the forecast period.

According to the report, the global plasma therapy industry was estimated at $350.21 million in 2020, and is anticipated to hit $698.46 million by 2030, registering a CAGR of 8.50% from 2021 to 2030.

For Right Perspective and Competitive Insights, Get Sample Report at: https://www.alliedmarketresearch.com/request-sample/14049

Drivers, restraints, and opportunities-

Increase in geriatric population, rise in prevalence of rare diseases, surge in number of plasma collection centers in the majority of countries, and upsurge in the number of androgenic alopecia patients across the world drive the growth of the global plasma therapy market. On the other hand, high cost of plasma derived products impedes the growth to some extent. However, high growth potential in the emerging economies has been highly beneficial for the market growth.

COVID-19 scenario-

Plasma from the blood of a patient who recovered from the COVID-19 is used for treatment of another patient suffering from COVID-19. Convalescent plasma can potentially develop as an effective treatment option to battle against the pandemic. This way, increase in demand for plasma derived immunoglobulins has driven the market growth of the plasma therapy market.
This trend is quite likely to continue till the pandemic is completely gone.
The pure platelet rich plasma segment to retain the lion's share-

On the basis of type, the pure platelet rich plasma segment held the major share in 2020, garnering nearly three-fifths of the global plasma therapy market. The same segment is projected to cite the fastest CAGR of 9.6% throughout the forecast period, owing to effective results of pure PRP therapies.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/14049

The orthopedics segment to dominate by 2030-

On the basis of application, the orthopedics segment contributed to the lion's share in 2020, holding nearly half of the global plasma therapy market, owing to increase in occurrences of orthopedic disorders such as arthritis and rise in healthcare expenditure among individuals. The same segment is also projected to manifest the fastest CAGR of 9.7% from 2021 to 2030.

North America held the major share in 2020-

By region, the market across North America dominated in 2020, garnering more than two-fifths of the global plasma therapy market, due to rise in research and developments made by government and private sectors propels the market growth in this region. Simultaneously, the Asia-Pacific region is expected to cite the fastest CAGR of 10.8% throughout the forecast period. Growing population and rise in awareness of blood donation among individuals in this region drive the market growth.

Key players in the industry-

Regen Lab SA
Zimmer Biomet
MTF Biologics
Arthrex
Terumo Corporation
Exactech, Inc.
Ony Biotech Inc.
Johnson & Johnson (DePuy Synthes)
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.

We also Offers Regional and Country Reports-

Japan Plasma Therapy Market
South Korea Plasma Therapy Market
Singapore Plasma Therapy Market
China Plasma Therapy Market
Indonesia Plasma Therapy Market
Australia Plasma Therapy Market
Taiwan Plasma Therapy Market

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

David Correa
Allied Analytics LLP
+1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.